THIS IS PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSE ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT, THIS DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES. THIS PUBLIC ANNOUNCEMENT IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY OUTSIDE INDIA.

LIOTECH INDUSTRIES LIMITED

The Corporate Identification Number of our Company is U27100GJ2020PLC114008

Our Company was originally incorporated as a private limited Company under the name of 'Liotech Industries Private Limited' on June 17, 2020 under the provisions of the Companies Act, 2013 with the Registrar of Companies, Central Registration Centre bearing registration number as U15400GJ2020PTC114008. Subsequently, pursuant to Special Resolution passed by the Shareholders at the Extra Ordinary General Meeting, held on February 06, 2024, our Company was converted into a Public Limited Company and consequently the name of our Company was changed from 'Liotech Industries Private Limited" to "Liotech Industries Limited" vide a fresh certificate of incorporation consequent upon conversion from private company to public company dated April 12, 2024 issued by the Registrar of Companies, Central Registration Centre bearing CIN U27100GJ2020PLC114008. For details pertaining to the changes of name of our company and change in the registered office, please refer to the chapter titled "History and Certain Corporate Matters" beginning on page no. Error! Bookmark not defined. of this Prospectus.

1. We depend on the success of our relationships with our customers. We derive a significant part of our revenue from our major customers and we do not have long term contracts with these customers. If one or more of such customers choose not to source their requirements from us, our business, financial condition and results of operations may be adversely affected.

2. We are highly dependent on our suppliers for uninterrupted supply of raw-materials. We have not entered into any long-term supply agreement for the major raw materials required for manufacturing of our products. Also volatility in the prices and non-availability of these raw materials may have an adverse impact in our business prospects, results of operations and financial condition.

3. Our business operations are majorly concentrated in certain geographical regions and any adverse developments affecting our operations in these regions could have a significant impact on our revenue and results of operations.

4. Certain delays, discrepancies and Omissions have been detected in our statutory records, as well as in records related to the submission of returns to the concerned Registrar of Companies.

5. Our Company has reported certain negative cash flows from its operating and investing activities, details of which are given below. Sustained negative cash flow could impact our growth and business in the future.

6. The intellectual Property Rights used by our company are "objected" and are not registered in the name of our company. Any failure to protect our intellectual property rights may adversely affect our business.

7. We intend to utilise a portion of the Net Proceeds for funding our capital expenditure requirements. We are yet to place orders 100% of the Plant & Machinery, as specified in the Objects of the Offer chapter. Any delay in procurement of such Rant & Machinery may delay the schedule of implementation and may also lead to increase in cost of these Plant & Machinery, further affecting our revenue and profitability.

8. We require working capital for our smooth day-to-day operations of business and any discontinuance or our inability to acquire adequate working capital timely and on favourable terms may have an adverse effect on our operations, profitability and growth prospects.

9. Our Company has entered into certain related party transactions in the past and may continue to do so in the future, which may potentially involve conflicts of interest with the equity shareholders.

10. The demand and pricing in the steel and steel products industry is volatile and is sensitive to the cyclical nature of the industries it serves.

• The Fixed Price Issue is Rs. 321/- per Equity Shares.

• Average Return on Net Worth for the period ended December 31st, 2025 is 34.44% and the financial year ended March 31st, 2025, 2024, and 2023 are 39.86%, 46.58% and 14.64% respectively.

• For further details please refer to the chapter titled 'Risk Factor' beginning on page no.29 of this Prospectus.

1. Disclosures as per clause (9)(K)(4) of Part A to Schedule VI, as applicable.

1. The price per share of our Company based on the primary/ new issue of shares (equity / convertible securities), excluding shares issued under ESOP/ESOS and issuance of bonus shares.

There has been no issuance of Equity Shares (excluding shares issued under ESOP/ESOS and issuance of bonus shares) during the 18 months preceding the date of this Prospectus, where such issuance is equal to or more than 5% of the fully diluted paid-up share capital of the Company (calculated based on the pre-offer capital before such transaction(s) and excluding employee stock options granted but not vested), in a single transaction or multiple transactions combined together over a span of 30 days.

2. The price per share of our Company based on the secondary sale / acquisition of shares (equity / convertible securities)

There have been no secondary sale / acquisitions of Equity Shares, where the promoters, members of the promoter group, selling shareholder or shareholder(s) having the right to nominate director(s) in the board of directors of the Company are a party to the transaction (excluding gifts), during the 18 months preceding the date of this Prospectus, where either acquisition or sale is equal to or more than 5% of the fully diluted paid-up share capital of the Company (calculated based on the pre-offer share capital before such transaction/s and excluding employee stock options granted but not vested), in a single transaction or multiple transactions combined together over a span of rolling 30 days.

3. Price per share based on the last five primary or secondary transactions

4. Weighted average cost of acquisition, offer price

The Issue was being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation), Rule, 1957, as amended ("SCRR") read with Regulation 229 of the SEBI ICDR Regulations and in compliance with Regulation 253 of the SEBI ICDR Regulation wherein not more than 50% of the Net Issue was available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"). Our Company in Consultation with BRLM allocated up to 60% of the QIB Portion to Anchor Investors on a discretionary basis (the "Anchor Investor Portion"). Further, not less than 15% of the Net Issue was available for allocation on proportionate basis to Non-Institutional Bidders and not less than 35% of the Net Issue was available for allocation to Retail Individual Investors in accordance with the SEBI ICDR Regulation, Subject to valid bids being received from them at or above the Issue Price. All potential Bidders (except Anchor Investors) are required to mandatorily utilize the Application Supported by Blocked Amount ("ASBA") process providing details of their respective bank account (including UPI ID for RIBs using UPI Mechanism), in which the corresponding Bid amounts will be blocked by the SCSBs or the Sponsor Bank, as applicable. Anchor Investors are not permitted to participate in the issue through the ASBA process. For details, see "Issue Procedure" on page no. 304 of the Prospectus.

This Corrigendum is issued in connection with the Prospectus dated June 10, 2026 and the Basis of Allotment finalized on June 22, 2026.

Investors are requested to note that Clause 5 of the "Basis of Allotment" appearing on page 269 of the Prospectus shall be read as under:

"If the Shares allotted on a proportionate basis to any category is more than the Shares allotted to the Applicants in that category, the balance available Shares or allocation shall be first adjusted against any category where the allotted Shares are not sufficient for proportionate allotment to the successful Applicants in that category. The balance Shares, if any, remaining after such adjustment shall be added to the category comprising Applicants applying for the minimum number of Shares.

Further, if as a result of the process of rounding off to the nearest multiple of 400 Equity Shares, the actual allotment exceeds the number of Equity Shares offered in the Issue, the final allotment may, at the sole discretion of the Board of Directors and in accordance with the Prospectus, be increased up to 110% of the Offer Size specified under the Capital Structure section of the Prospectus."

Accordingly, while finalizing the Basis of Allotment, 80,400 Equity Shares remaining unutilized from the Non-Institutional Investor category were adjusted to the Retail Individual Investor category in accordance with the aforesaid provision of the Prospectus. Further, due to rounding off of allotments to the nearest multiple of 400 Equity Shares, an additional 400 Equity Shares were allotted. Consequently, the final allotment aggregated to 11,22,400 Equity Shares as against the original Offer Size of 11,22,000 Equity Shares.

Note: - All other terms used and not defined herein shall have the respective meanings assigned to them in the prospectus dated June 10, 2026 ('Prospectus') filed with Registrar of Companies, Ahmedabad.

The Issue received 2252 applications for 21,02,800 Equity Shares resulting in 1.87 times subscription as disclosed in the Prospectus. The details of the applications received in the Offer from Individual Investor Bidders. Non-Institutional Bidders and Market Maker are as under (before technical rejections):

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange being BSE Limited on 22nd June, 2026.

1. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the issue price of Rs. 321/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 58,000 Equity shares, out of reserved portion of 58,000 Equity Shares.

2. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal, if any): The Basis of Allotment to the Retail Individual Investors, who have bid at the Issue Price of Rs. 321/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 2.55 times i.e. for 15,60,000 Equity Shares. The total number of shares allotted in this category is 6,12,800 Equity shares as under:

->Includes spillover of 80,400 Equity shares from Non-Institutional Investor category and Increased 400 equity shares on Offer size for the purpose of allotment.

3. Allocation to Non-Institutional Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non-Institutional Investors, who have at issue price of Rs. 321/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 0.85 times i.e. 4,51,600 Equity Shares the total number of shares allotted in this category is 4,51,600 Equity Shares. The category wise basis of allotment is as under:

-> Unsubscribed portion of 80,400 Equity Shares spill over to Individual Investors Category

The Board of Directors of the Company at its meeting held on June 22, 2026 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. BSE and has authorized the corporate action for allotment of shares in dematerialized form to various successful applicants. The allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories. Further the instructions to Self-Certified Syndicate Banks were being processed on or before June 22, 2026. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the SME Platform of BSE within three working days from the date of the closure of the Issue. The trading is proposed to be commenced on Wednesday, June 24, 2026 subject to receipt of final listing and trading approval from the BSE.

Note: All capitalized terms used and not defined herein shall have the respective meaning assigned to them in the Prospectus dated June 10, 2026 ("Prospectus") filed with the Registrar of Company, Ahmedabad.

The details of the allotment made would also be hosted on the website of the Registrar to the issue, KFIN TECHNOLOGIES LIMITED at www.purvashare.com. All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

KFIN TECHNOLOGIES LIMITED

Address: 301, The Centrium, 3rd Floor 57, Lai Bahadur Shastri Road, Nav Pada, Kurla (West), Kurla, Mumbai, Maharashtra, India, 400070

Tel. Number: +91 40 6716 2222/18003094001

Website: www.kfintech.com

Email Id: liotech.ipo@kfintech.com

Investors Grievance: einward.ris@kfintech.com

Contact Person: Mr. M. Murli Krishna

SEBI Registration Number: INR000000221

LIOTECH INDUSTRIES LIMITED is proposing, subject to market conditions and other considerations, a public issue of its Equity Shares and has filed the Prospectus with the Registrar of Companies, Ahmedabad ("ROC"). The Prospectus is available on the website of the SEBl at (www.sebi.gov.in), the website of the Book Running Lead Manager at (www.wealthminenetworks.com) and website of Company at (www.liotechindustries.in) and on the website of BSE Limited at (www.bseindia.com) . Investor should note that investment in equity shares involved high degree of risk. For details, investors should refer to and reply on the Prospectus, including the section titled "Risk Factors" on page no. 39 of the Prospectus, which has been filed with ROC, before making any investment decision. The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933 as amended ("The Security Act") and may not be issued or sold within the United States (as defined in regulations under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirement of the Securities Act. The equity shares are being offered and sold only outside the United States in offshore transaction in compliance with regulations under the Securities Act and the applicable laws of the jurisdiction where those offers and sales occurs.